395 related articles for article (PubMed ID: 15230629)
21. A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumors.
Witta SE; Gustafson DL; Pierson AS; Menter A; Holden SN; Basche M; Persky M; O'Bryant CL; Zeng C; Baron A; Long ME; Gibbs A; Kelly K; Bunn PA; Chan DC; Pallansch P; Eckhardt SG
Clin Cancer Res; 2004 Nov; 10(21):7229-37. PubMed ID: 15534096
[TBL] [Abstract][Full Text] [Related]
22. A phase I/II study of exisulind in combination with docetaxel/carboplatin in patients with metastatic non-small-cell lung cancer.
Jones SF; Kuhn JG; Greco FA; Raefsky EL; Hainsworth JD; Dickson NR; Thompson DS; Willcutt NT; White MB; Burris HA
Clin Lung Cancer; 2005 May; 6(6):361-6. PubMed ID: 15943897
[TBL] [Abstract][Full Text] [Related]
23. Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis.
van Stolk R; Stoner G; Hayton WL; Chan K; DeYoung B; Kresty L; Kemmenoe BH; Elson P; Rybicki L; Church J; Provencher K; McLain D; Hawk E; Fryer B; Kelloff G; Ganapathi R; Budd GT
Clin Cancer Res; 2000 Jan; 6(1):78-89. PubMed ID: 10656435
[TBL] [Abstract][Full Text] [Related]
24. Bleomycin--electrical pulse delivery: electroporation therapy-bleomycin--Genetronics; MedPulser-bleomycin--Genetronics.
Drugs R D; 2004; 5(5):293-6. PubMed ID: 15357628
[TBL] [Abstract][Full Text] [Related]
25. Gadofosveset: MS 325, MS 32520, Vasovist, ZK 236018.
Drugs R D; 2004; 5(6):339-42. PubMed ID: 15563237
[TBL] [Abstract][Full Text] [Related]
26. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
[TBL] [Abstract][Full Text] [Related]
27. Methylnaltrexone: MNTX.
Drugs R D; 2006; 7(6):374-8. PubMed ID: 17073520
[TBL] [Abstract][Full Text] [Related]
28. Decitabine: 2'-deoxy-5-azacytidine, Aza dC, DAC, dezocitidine, NSC 127716.
Drugs R D; 2003; 4(6):352-8. PubMed ID: 14584964
[TBL] [Abstract][Full Text] [Related]
29. Sulindac and its derivatives: a novel class of anticancer agents.
Haanen C
Curr Opin Investig Drugs; 2001 May; 2(5):677-83. PubMed ID: 11569947
[TBL] [Abstract][Full Text] [Related]
30. Mismatched double-stranded RNA: polyI:polyC12U.
Adis Editorial
Drugs R D; 2004; 5(5):297-304. PubMed ID: 15357629
[TBL] [Abstract][Full Text] [Related]
31. A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (E1501).
Masters GA; Li S; Dowlati A; Madajewicz S; Langer C; Schiller J; Johnson D
J Thorac Oncol; 2006 Sep; 1(7):673-8. PubMed ID: 17409935
[TBL] [Abstract][Full Text] [Related]
32. Abarelix: abarelix-depot-F, abarelix-depot-M, abarelix-L, PPI 149, R 3827.
Drugs R D; 2003; 4(3):161-6. PubMed ID: 12757402
[TBL] [Abstract][Full Text] [Related]
33. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis.
Stoner GD; Budd GT; Ganapathi R; DeYoung B; Kresty LA; Nitert M; Fryer B; Church JM; Provencher K; Pamukcu R; Piazza G; Hawk E; Kelloff G; Elson P; van Stolk RU
Adv Exp Med Biol; 1999; 470():45-53. PubMed ID: 10709673
[TBL] [Abstract][Full Text] [Related]
34. Vernakalant: RSD 1235, RSD-1235, RSD1235.
Drugs R D; 2007; 8(4):259-65. PubMed ID: 17596113
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
[TBL] [Abstract][Full Text] [Related]
36. Exenatide: AC 2993, AC002993, AC2993A, exendin 4, LY2148568.
Drugs R D; 2004; 5(1):35-40. PubMed ID: 14725490
[TBL] [Abstract][Full Text] [Related]
37. Motexafin gadolinium: gadolinium (III) texaphyrin, gadolinium texaphyrin, Gd-Tex, GdT2B2, PCI 0120.
Drugs R D; 2004; 5(1):52-7. PubMed ID: 14725495
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronidase (Vitrase)--ISTA: hyaluronidase--ISTA pharmaceuticals.
Drugs R D; 2003; 4(3):194-7. PubMed ID: 12757408
[TBL] [Abstract][Full Text] [Related]
39. Oxipurinol: alloxanthine, Oxyprim, oxypurinol.
Drugs R D; 2004; 5(3):171-5. PubMed ID: 15139781
[TBL] [Abstract][Full Text] [Related]
40. Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival.
Whitehead CM; Earle KA; Fetter J; Xu S; Hartman T; Chan DC; Zhao TL; Piazza G; Klein-Szanto AJ; Pamukcu R; Alila H; Bunn PA; Thompson WJ
Mol Cancer Ther; 2003 May; 2(5):479-88. PubMed ID: 12748310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
